Royal Philips has announced the commercial launch of Philips NightBalance for patients with positional obstructive sleep apnea, which uses gentle vibrations to encourage users to alter their sleeping positions to help prevent apneas. The new positional OSA technology has wireless connectivity and a mobile app that monitors usage and stores the data on the cloud for easy access. NightBalance will be available via prescription in Austria, Belgium, Germany, Luxembourg, the Netherlands, Switzerland, the UK and the US.
In a recent study funded by Philips in the Journal of Clinical Sleep Medicine, The POSAtive Study: Study for the Treatment of Positional Obstructive Sleep Apnea, data showed that patients with positional OSA felt NightBalance was easier to use, easier to adjust to and more comfortable than other PAP therapy methods. Patients who used NightBalance also used the device for longer versus PAP therapy, with 74% of patients reported using it for over four hours, versus 64.9%.
“Philips launches new product for treatment of positional OSA“
Mark D’Angelo, Sleep OSA Business Leader at Philips, said: “We are always looking to evolve our solutions to help people living with sleep apnea take control of their health. The right sleep therapy varies person-to-person, and for those who suffer from positional obstructive sleep apnea, it can be defeating when traditional therapies don’t meet their specific needs. With Philips NightBalance, positional obstructive sleep apnea patients now have a non-invasive and comfortable treatment option that can be successful, resulting in long term therapy adherence.”